Atom | Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

Funder: National Institutes of Health

Funding Amounts: Up to $275,000 in direct costs over 2 years; no more than $200,000 in any single year.

Summary: Supports exploratory/developmental research on HIV/AIDS within NIDCD mission areas, focusing on hearing, balance, taste, smell, voice, speech, and language.

Key Information: Only low risk clinical trials are supported; see NOFO for restrictions.

Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)

Sign in to see full grant listing